Product Name: EPM2AIP1 antibody [N1], N-term
Applications: WB
Predicted Target Size: 70 kDa (note)
Positive Controls: 293T , A431 , H1299
Form Supplied: Liquid
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: EPM2A (laforin) interacting protein 1
Background: The EPM2A gene, which encodes laforin, is mutated in an autosomal recessive form of adolescent progressive myoclonus epilepsy. The protein encoded by this gene binds to laforin, but its function is not known. This gene is intronless. [provided by RefSeq]
Synonyms: FLJ11207 antibody, KIAA0766 antibody, EPM2AIP1 antibody, laforin-interacting protein antibody, EPM2A interacting protein 1 antibody, EPM2A-interacting protein 1 antibody, EPM2A (laforin) interacting protein 1 antibody
Cellular Localization: Endoplasmic reticulum
CAS NO: 1800401-93-7
Product: RAF265
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Carrier-protein conjugated synthetic peptide encompassing a sequence within the N-terminus region of human EPM2AIP1. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: 0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/18826648?dopt=Abstract
